参考文献/References:
[1] CHEN S J,LIN C S,LIN C L,et al.Osteoporosis is associ-ated with high risk for coronary heart disease:A Population-based Cohort Study[J].Medicine(Baltimore),2015,94(27):e1146.
[2] LEE S N,CHO J Y,EUN Y M,et al.Associations between osteoporosis and coronary artery disease in postmenopausal women[J].Climacteric,2016,19(5):458-462.
[3] 祁慧萌,赵心,王爽,等.中老年骨质疏松与下肢动脉粥样硬化相关性分析[J].中华实用诊断与治疗杂志,2016,30(5):478-480.
[4] MIN H,MORONY S,SAROSI I,et al.Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis[J].J Exp Med,2000,192(4):463-474.
[5] ORITA Y,YAMAMOTO H,KOHNO N,et al.Role of osteoprotegerin in arterial calcification development of new animal model[J].Arterioscler Thromb Vasc Biol,2007,27(9):2058-2064.
[6] CALLEGARI A,COONS M L,RICKS J L,et al.Increased calcification in osteoprotegerin-deficient smooth muscle cells:Dependence on receptor activator of NF-κB ligand and interleukin 6[J].J Vasc Res,2014,51(2):118-131.
[7] WINKLER D G,SUTHERLAND M K,GEOGHEGAN J C,et al.Osteocyte control of bone formation via sclerostin,a novel BMP antagonist[J].EMBO J,2003,22(23):6267-6276.
[8] 张树东,祝孟海,李世飞,等.骨硬化蛋白与骨质疏松:治疗的新方向[J].中国组织工程研究,2017,21(36):5847-5854.
[9] 刘蕾,张树俭,徐晓娜,等.腹膜透析患者血清骨硬化蛋白与冠状动脉钙化及骨密度的关系[J].中国中西医结合肾病杂志,2018,19(7):592-595.
[10] KOOS R,BRANDENBURG V,MAHNKEN A H,et al.Sclerostin as a potential novel biomarker for aortic valve calcification:an in-vivo and ex-vivo study[J].J Heart Valve Dis,2013,22(3):317-325.
[11] 位艳伟,柳达,付平,等.血清铁蛋白与血清铁调素在老年原发性高血压合并骨质疏松中作用的研究[J].中国骨质疏松杂志,2018,24(1):87-90.
[12] 孙瑞华.冠心病患者血清铁蛋白、总铁结合力、血清铁蛋白/总铁结合力水平与冠状动脉病变及心血管事件的关系[J].中国卫生检验杂志,2017,27(13):1897-1899.
[13] 张迪晖,黄泽鑫,罗斌.体检女性血清铁蛋白与骨密度的关系[J].中国医药导报,2018,15(25):75-78.
[14] 经保生,贾鹏,陆政峰,等.唑来膦酸治疗椎体骨质疏松的疗效与铁蓄积的相关性[J].中华骨质疏松和骨矿盐疾病杂志,2018,11(2):126-130.
[15] CHON S J,CHOI Y R,ROH Y H,et al.Association between levels of serum ferritin and bone mineral density in Korean premenopausal and postmenopausal women:KNHANES 2008-2010[J].PLoS One,2014,9(12):e114972.
[16] FELDBRIN Z,LUCKISH A,SHARGORODSKY M.Effects of long-term risedronate treatment on serum ferritin levels in postmenopausal women with osteoporosis:the impact of cardiovascular risk factor load[J].Menopause,2016,23(1):55-59.
[17] 童雪影,唐祖胜,陈敏,等.骨桥蛋白的增龄性变化对骨质疏松症的影响[J].中国老年保健医学,2015,13(4):42-43.
[18] LUNA-LUNA M,CRUZ-ROBLES D,áVILA-VANZZINI N,et al.Differential expression of osteopontin,and osteoprotegerin mRNA in epicardial adipose tissue between patients with severe coronary artery disease and aortic valvular stenosis:association with HDL subclasses[J].Lipids Health Dis,2017,16(1):156.
[19] 王和鸣,黄桂成.中医骨伤科学[M].3版.北京:中国中医药出版社,2013:373-374.
[20] 陈志强,杨关林.中西医结合内科学[M].3版.北京:中国中医药出版社,2018:175.
[21] 王永炎,常富业,杨宝琴.病络与络病对比研究[J].北京中医药大学学报,2005,28(3):1-6.
[22] 邱瑞瑾,高永红,商洪才,等.病络理论指导下脑、心、肾一体化中西医结合防治体系的构建[J].中医杂志,2016,57(5):361-365.
[23] 李红梅,王婧文,孙晓婷,等.络风内动与动脉粥样硬化斑块内血管新生[J].中医杂志,2017,58(17):1462-1465.
[24] 何伟.心肺系疾病继发骨质疏松症的病络机制及科学内涵[J].中国骨质疏松杂志,2018,24(9):1241-1245.
[25] 荣杰,许颖智,张军平.冠心病患者介入术前后中医证候演变规律分析[J].中医杂志,2012,53(23):2027-2030.
[26] 漆仲文,王晓景,仲爱芹,等.基于育心保脉理论调治冠心病危险因素[J].中医杂志,2017,58(14):1192-1195.
[27] 韩秀文,王进.心肾相交理论对治疗骨质疏松症指导作用的研究[J].湖北中医杂志,2011,33(6):32-33.
[28] 朱伟慧,张力.老年人骨质疏松与颈动脉硬化间的相关性分析及干预策略[J].中国老年学杂志,2015,35(23):6869-6871.
[29] 汪弢,卢辉和,盛臻强,等.骨质疏松症与冠状动脉病变严重程度的相关性分析[J].中国现代医学杂志,2018,28(6):118-121.
相似文献/References:
[1]李林军.应用膨胀式椎弓根螺钉内固定治疗合并骨质疏松的
胸腰椎退行性疾病[J].中医正骨,2015,27(08):49.
[2]韩艳,温利平,刘娜,等.补肾活血方对去卵巢大鼠骨代谢及骨密度的影响[J].中医正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(补肾活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):7.
[3]李学朋,朱立国.骨疏康胶囊对去卵巢大鼠骨小梁的影响[J].中医正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康胶囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):12.
[4]陈冠军,陈扬,庄汝杰.可灌注骨水泥椎弓根螺钉系统
在老年腰椎疾患手术中的应用[J].中医正骨,2015,27(02):40.
[5]王丹辉,贲越,韩梅.林蛙油治疗绝经后骨质疏松症的临床研究[J].中医正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(08):27.
[6]黄建华,黄建武,李慧辉,等.加味左归丸对绝经后骨质疏松症肝肾不足证
患者骨密度的影响[J].中医正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(08):19.
[7]项旻,杨虹,林爱菊,等.绝经后2型糖尿病患者骨质疏松与血微量元素的关系研究[J].中医正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(08):20.
[8]史晓林,李春雯,张志强.弱阳离子磁珠分离技术和基质辅助激光解吸电离飞行时间质谱技术在原发性Ⅰ型骨质疏松症血清标志蛋白筛选中的应用[J].中医正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(08):5.
[9]李明,徐明雄,冯左基,等.自拟壮骨方治疗绝经后骨质疏松症的疗效及作用机制研究[J].中医正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(08):21.
[10]陈俊杰,李晴晴,夏瑢.脂代谢及血清内脂素水平与绝经后骨质疏松症的
相关性研究[J].中医正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(08):16.